Literature DB >> 12768032

Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection.

Barbra A Richardson1, Dorothy Mbori-Ngacha, Ludo Lavreys, Grace C John-Stewart, Ruth Nduati, Dana D Panteleeff, Sandra Emery, Joan K Kreiss, Julie Overbaugh.   

Abstract

Steady-state levels of human immunodeficiency virus type 1 (HIV-1) RNA in plasma reached at approximately 4 months postinfection are highly predictive of disease progression. Several studies have investigated viral levels in adults or infants during primary and early infection. However, no studies have directly compared these groups. We compared differences in peak and set point plasma HIV-1 RNA viral loads among antiretrovirus-naive Kenyan infants and adults for whom the timing of infection was well defined. Peak and set point viral loads were significantly higher in infants than in adults. We did not observe any gender-specific differences in viral set point in either adults or infants. However, infants who acquired HIV-1 in the first 2 months of life, either in utero, intrapartum, or through early breast milk transmission, had significantly higher set point HIV-1 RNA levels than infants who were infected after 2 months of age through late breast milk transmission or adults who were infected through heterosexual transmission.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768032      PMCID: PMC156211          DOI: 10.1128/jvi.77.12.7120-7123.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group.

Authors:  W T Shearer; T C Quinn; P LaRussa; J F Lew; L Mofenson; S Almy; K Rich; E Handelsman; C Diaz; M Pagano; V Smeriglio; L A Kalish
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

2.  Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study.

Authors:  D Pugatch; J L Sullivan; C A Pikora; K Luzuriaga
Journal:  J Infect Dis       Date:  1997-09       Impact factor: 5.226

3.  Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics.

Authors:  P Krogstad; C H Uittenbogaart; R Dickover; Y J Bryson; S Plaeger; A Garfinkel
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

4.  Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus.

Authors:  K McIntosh; A Shevitz; D Zaknun; J Kornegay; P Chatis; N Karthas; S K Burchett
Journal:  Pediatr Infect Dis J       Date:  1996-12       Impact factor: 2.129

5.  Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.

Authors:  P E Palumbo; C Raskino; S Fiscus; S Pahwa; M G Fowler; S A Spector; J A Englund; C J Baker
Journal:  JAMA       Date:  1998-03-11       Impact factor: 56.272

6.  Biological and virologic characteristics of primary HIV infection.

Authors:  T W Schacker; J P Hughes; T Shea; R W Coombs; L Corey
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

7.  Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA.

Authors:  D D Panteleeff; G John; R Nduati; D Mbori-Ngacha; B Richardson; J Kreiss; J Overbaugh
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

8.  Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome.

Authors:  R E Dickover; M Dillon; K M Leung; P Krogstad; S Plaeger; S Kwok; C Christopherson; A Deveikis; M Keller; E R Stiehm; Y J Bryson
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

9.  Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.

Authors:  E J Abrams; J Weedon; R W Steketee; G Lambert; M Bamji; T Brown; M L Kalish; E E Schoenbaum; P A Thomas; D M Thea
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

10.  Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group.

Authors:  G R Kaufmann; P Cunningham; A D Kelleher; J Zaunders; A Carr; J Vizzard; M Law; D A Cooper
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  52 in total

1.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

2.  HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment.

Authors:  Katherine Luzuriaga; Barbara Tabak; Manuel Garber; Ya Hui Chen; Carrie Ziemniak; Margaret M McManus; Danielle Murray; Matthew C Strain; Douglas D Richman; Tae-Wook Chun; Coleen K Cunningham; Deborah Persaud
Journal:  J Infect Dis       Date:  2014-05-21       Impact factor: 5.226

3.  In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth.

Authors:  B Lohman-Payne; T Sandifer; M OhAinle; C Crudder; J Lynch; M M Omenda; J Maroa; K Fowke; G C John-Stewart; C Farquhar
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

4.  Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.

Authors:  Bhavna H Chohan; Kenneth Tapia; Sarah Benki-Nugent; Brian Khasimwa; Musa Ngayo; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Julie Overbaugh; Grace John-Stewart
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-22       Impact factor: 2.205

5.  Laser cutting eliminates nucleic acid cross-contamination in dried-blood-spot processing.

Authors:  Sean C Murphy; Glenda Daza; Ming Chang; Robert Coombs
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

6.  Mother-to-child transmission of HIV: a global perspective.

Authors:  Katherine Luzuriaga
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

7.  Timely triggering of homeostatic mechanisms involved in the regulation of T-cell levels in SIVsm-infected sooty mangabeys.

Authors:  Alagarraju Muthukumar; Dejiang Zhou; Mirko Paiardini; Ashley P Barry; Kelly S Cole; Harold M McClure; Silvija I Staprans; Guido Silvestri; Donald L Sodora
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

8.  Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Elias Woldegabriel; Lemme Kebaabetswe; Raabya Rossenkhan; Busisiwe Mlotshwa; Caitlin Bonney; Mariel Finucane; Rosemary Musonda; Sikhulile Moyo; Carolyn Wester; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

Review 9.  The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies.

Authors:  Kristina Abel
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

10.  Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.

Authors:  Merlin L Robb; Leigh A Eller; Hannah Kibuuka; Kathleen Rono; Lucas Maganga; Sorachai Nitayaphan; Eugene Kroon; Fred K Sawe; Samuel Sinei; Somchai Sriplienchan; Linda L Jagodzinski; Jennifer Malia; Mark Manak; Mark S de Souza; Sodsai Tovanabutra; Eric Sanders-Buell; Morgane Rolland; Julie Dorsey-Spitz; Michael A Eller; Mark Milazzo; Qun Li; Andrew Lewandowski; Hao Wu; Edith Swann; Robert J O'Connell; Sheila Peel; Peter Dawson; Jerome H Kim; Nelson L Michael
Journal:  N Engl J Med       Date:  2016-05-18       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.